Jenny Rooke is a Managing Director at Genoa Ventures, a firm that specializes in investing in early-stage companies at the intersection of biology and technology since 2012. In addition to this role, Jenny Rooke serves as an investor and board observer for several organizations, including Fellow, BrightSpec, Inc., General Inception, Redux Bio, Stemson Therapeutics, Meiogenix, Aqtual, Inc., and Tropic. Furthermore, Jenny Rooke holds a position on the Board of Trustees at The Jackson Laboratory. Educational credentials include a Ph.D. in Genetics from Yale University and a BS in Physics from the Georgia Institute of Technology.